6
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neurocognitive and Psychosocial Characteristics of Pediatric Patients With Post-Acute/Long-COVID: A Retrospective Clinical Case Series

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Studies suggest a large number of patients have persistent symptoms following COVID-19 infection—a condition termed “long COVID.” Although children and parents often report cognitive difficulties after COVID, very few if any studies have been published including neuropsychological testing.

          Methods

          A retrospective chart review was completed for the first 18 patients referred for a neuropsychological evaluation from a multidisciplinary pediatric post-COVID clinic. The neuropsychological screening battery assessed verbal fluency and category switching, attention, working memory, processing speed, and verbal learning and memory. Patients’ caregivers also completed standardized questionnaires regarding day-to-day mood and behavior.

          Results

          At intake, the most common neurologic symptoms reported by caregivers were attention problems (83.3%), fatigue/lethargy (77.7%), sleep disturbance (77.7%), dizziness/vertigo (72.2%), and headaches (72.2%). On rating scales, most caregivers endorsed concerns for depressed mood and anxiety (14/15 and 12/15). A large proportion of patients had difficulties with attention (9/18) and depressed mood/anxiety (13/18) before COVID. On cognitive testing, the majority of the patients performed within or above broad average range (≥16th percentile) across most domains. However, a little over half of the patients performed below average on auditory attention measures.

          Conclusions

          Within our clinically referred sample, children who reported lingering cognitive symptoms after COVID-19 often had a preexisting history of attention and/or mood and anxiety concerns. Many of these patients performed below average in attention testing, but it remains to be seen whether this was due to direct effects of COVID, physical symptoms, and/or preexisting difficulties with attention or mood/anxiety.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

          Summary The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults

            Abstract Aim The coronavirus disease 2019 (COVID‐19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. Methods A systematic literature review was carried out to identify papers on COVID‐19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. Results The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%‐5% of diagnosed COVID‐19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID‐19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. Conclusions The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare.
              • Record: found
              • Abstract: found
              • Article: not found

              Nervous system involvement after infection with COVID-19 and other coronaviruses

              Highlights • Coronoviruses not only affect the respiratory system, but also have deleterious effects on the central nervous system. • Most neurological diseases could be caused by coronoviruses invasion. • Coronoviruses cause nerve damage via diverse pathways.

                Author and article information

                Contributors
                Journal
                Arch Clin Neuropsychol
                Arch Clin Neuropsychol
                acn
                Archives of Clinical Neuropsychology
                Oxford University Press
                0887-6177
                1873-5843
                29 July 2022
                29 July 2022
                : acac056
                Affiliations
                Kennedy Krieger Institute , Baltimore, MD, USA
                Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine , Baltimore, MD, USA
                Kennedy Krieger Institute , Baltimore, MD, USA
                Kennedy Krieger Institute , Baltimore, MD, USA
                Kennedy Krieger Institute , Baltimore, MD, USA
                Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine , Baltimore, MD, USA
                Kennedy Krieger Institute , Baltimore, MD, USA
                Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine , Baltimore, MD, USA
                Department of Neurology, Johns Hopkins School of Medicine , Baltimore, MD, USA
                Author notes
                Corresponding author at: Department of Neuropsychology, Kennedy Krieger Institute, 1750 E. Fairmount Ave. Tel.: 443-923-4456; fax: 443-923-4403. E-mail address: ngr@ 123456kennedykrieger.org (R. Ng).
                Author information
                https://orcid.org/0000-0001-7193-4300
                Article
                acac056
                10.1093/arclin/acac056
                9384547
                35901463
                0b176851-2222-48c4-a4e6-72a82c24bafe
                © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

                This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                : 11 January 2022
                : 28 June 2022
                : 1 July 2022
                Page count
                Pages: 11
                Categories
                Case Report
                AcademicSubjects/SCI01870
                AcademicSubjects/SCI02190
                Custom metadata
                PAP

                Clinical Psychology & Psychiatry
                post-acute covid syndrome,long covid,sars-cov-2,attention,neuropsychiatry,covid-19

                Comments

                Comment on this article

                Related Documents Log